Terms: = Ovarian cancer AND EIF4A2, DDX2B, 1974, ENSG00000156976, EIF4F, BM-010, EIF4A AND Staging
6 results:
1. Predictive factors of recurrence in patients with early-stage epithelial ovarian cancer.
Ditto A; Leone Roberti Maggiore U; Bogani G; Martinelli F; Chiappa V; Evangelista MT; Liberale V; Ferrero S; Raspagliesi F
Int J Gynaecol Obstet; 2019 Apr; 145(1):28-33. PubMed ID: 30698271
[TBL] [Abstract] [Full Text] [Related]
2. Associated primary tumors in patients with gastric cancer.
Dinis-Ribeiro M; Lomba-Viana H; Silva R; Moreira-Dias L; Lomba-Viana R
J Clin Gastroenterol; 2002; 34(5):533-5. PubMed ID: 11960064
[TBL] [Abstract] [Full Text] [Related]
3. Adjuvant therapy with intraperitoneal chromic phosphate (32P) in women with early ovarian carcinoma after comprehensive surgical staging.
Soper JT; Berchuck A; Dodge R; Clarke-Pearson DL
Obstet Gynecol; 1992 Jun; 79(6):993-7. PubMed ID: 1579329
[TBL] [Abstract] [Full Text] [Related]
4. Determinants of survival of patients with epithelial ovarian carcinoma following whole abdomen irradiation (WAR).
Weiser EB; Burke TW; Heller PB; Woodward J; Hoskins WJ; Park RC
Gynecol Oncol; 1988 Jun; 30(2):201-8. PubMed ID: 3371745
[TBL] [Abstract] [Full Text] [Related]
5. Stage II invasive adenocarcinoma of the ovary: results of treatment by whole abdominal radiation plus pelvic boost versus pelvic radiation plus oral melphalan chemotherapy.
Piver MS; Lele SB; Patsner B; Krishnamsetty R; Emrich LJ
Gynecol Oncol; 1986 Feb; 23(2):168-75. PubMed ID: 3943758
[TBL] [Abstract] [Full Text] [Related]
6. Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation).
Cohen CJ; Goldberg JD; Holland JF; Bruckner HW; Deppe G; Gusberg SB; Wallach RC; Kabakow B; Rodin J
Am J Obstet Gynecol; 1983 Apr; 145(8):955-67. PubMed ID: 6404174
[TBL] [Abstract] [Full Text] [Related]
